DOV Pharmaceutical Inc

DOV Pharmaceutical Inc discloses dealings in DOV Pharmaceutical Inc to SEC (Form 4). Over a trading history stretching from 10 January 2006 to 3 April 2008, the count stands at 61 filings.

On the open market, the record shows 3 purchases worth €7,656 and 49 sales worth €6.8M. Taken together, the sales exceed the purchases by €6.8M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant. In 2008 alone, the filings show 2 purchases and no sales.

The median purchase comes to €3,368.

The latest filing, published on 8 April 2008, reports an open-market purchase of €3,368 in DOV Pharmaceutical Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.